137 related articles for article (PubMed ID: 25381554)
1. Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.
Li Y; Yang H; Zou X; Xiong L; Li Z; Luo J; Zhao B; Liu W; Du X
Med Sci Monit; 2014 Nov; 20():2213-8. PubMed ID: 25381554
[TBL] [Abstract][Full Text] [Related]
2. CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019.
Wang T; Zhao T; Bao S; Jia L; Feng J; Yu A; Sun L; Guo X; Li H; Yu L
Medicine (Baltimore); 2020 Jul; 99(29):e20582. PubMed ID: 32702814
[TBL] [Abstract][Full Text] [Related]
3. Association between -44G/A and +71A/G polymorphisms in the connexin 40 gene and atrial fibrillation in Uyghur and Han populations in Xinjiang, China.
Hailati J; Yang YC; Zhang L; He PY; Baikeyi M; Muhuyati W; Liu ZQ
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27813566
[TBL] [Abstract][Full Text] [Related]
4. Difference in DRB1* gene polymorphisms between Han and Uyghur ulcerative colitis patients in China.
Aheman A; Gao F; Kuerbanjiang A; Li YX; Abuduhadeer M
World J Gastroenterol; 2013 May; 19(17):2709-13. PubMed ID: 23674880
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutations in non-syndromic deafness patients of Uyghur and Han Chinese ethnicities in Xinjiang, China: a comparative study.
Chen Y; Tudi M; Sun J; He C; Lu HL; Shang Q; Jiang D; Kuyaxi P; Hu B; Zhang H
J Transl Med; 2011 Sep; 9():154. PubMed ID: 21917135
[TBL] [Abstract][Full Text] [Related]
6. Individuals having variant genotypes of cytochrome P450 2C19 are at increased risk of developing primary liver cancer in Han populations, without infection with the hepatitis virus.
Li QY; Zhao NM; Wang LC; Duan HF; Ma YC; Zhang W; Zhao HW; Qin YH
Tumour Biol; 2014 Sep; 35(9):9023-6. PubMed ID: 24906606
[TBL] [Abstract][Full Text] [Related]
7. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
8. Distribution of HLA-DQA1, -DQB1 and -DRB1 genes and haplotypes in Han, Uyghur, Kazakh and Hui populations inhabiting Xinjiang Uyghur Autonomous Region, China.
Zhou C; Xu M; Xiao Z; Yuan J; Wu Y; Gao B; Hui W; Gao F; Chen H
Int J Immunogenet; 2021 Jun; 48(3):229-238. PubMed ID: 33527680
[TBL] [Abstract][Full Text] [Related]
9. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068
[TBL] [Abstract][Full Text] [Related]
10. Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.
Zhong Z; Hou J; Li B; Zhang Q; Liu S; Li C; Liu Z; Yang M; Zhong W; Zhao P
Med Sci Monit; 2017 Dec; 23():6186-6192. PubMed ID: 29288619
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism analysis of cytochrome P4502C19 in Chinese Uigur and Han populations.
Niu CY; Luo JY; Hao ZM
Chin J Dig Dis; 2004; 5(2):76-80. PubMed ID: 15612662
[TBL] [Abstract][Full Text] [Related]
12. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
Zhong Z; Hou J; Zhang Q; Li B; Li C; Liu Z; Yang M; Zhong W; He X; Wu H; Zhong M; Zhao P
Eur J Clin Pharmacol; 2018 Apr; 74(4):423-431. PubMed ID: 29243114
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
[TBL] [Abstract][Full Text] [Related]
15. Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease.
Ma L; Yuan Y; Li J; Yu C; Zhao J
Int J Immunogenet; 2020 Dec; 47(6):539-545. PubMed ID: 32862511
[TBL] [Abstract][Full Text] [Related]
16. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.
Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH
J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
[TBL] [Abstract][Full Text] [Related]
18. Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation.
Zhang H; Ma K; Liu W; Yang F; Liu J; Zhou H
Gene; 2016 Oct; 591(1):80-84. PubMed ID: 27356304
[TBL] [Abstract][Full Text] [Related]
19. Association between CYP2C19 gene polymorphisms and lipid metabolism in Chinese patients with ischemic stroke.
Bai Y; Huang R; Wan L; Zhao R
J Int Med Res; 2020 Jul; 48(7):300060520934657. PubMed ID: 32644829
[TBL] [Abstract][Full Text] [Related]
20. CYP2C19 gene polymorphism in Ningxia.
Yang Z; Xie Y; Zhang D; Zou Y; Li X; Chen R; Zhang X; Chen S; Bai F
Pharmacol Rep; 2023 Jun; 75(3):705-714. PubMed ID: 36913175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
